Doug Jennings, Pharm.D.
@prof_j_nyc
Professor & Dept Chair | Heart Transplant & MCS @Columbia | ACC HF/TXP Leadership Council | Editorial Board @jcardfail | @ISHLT Guideline Co-author
ID: 1156731406841733120
01-08-2019 01:00:33
518 Tweet
1,1K Followers
267 Following
APPE artwork ๐ผ๏ธ alert โผ๏ธ ๐จ When the game of Life meets Mt. Tsukuba ๐ป๐ #TwitteRx @accpimtrprn Shirley Hanania
Immunosuppression use & differences between agents in adult heart transplant recipients before and after the UNOS allocation policy change. buff.ly/3vymm0F William Baker Doug Jennings, Pharm.D. UConn Pharmacy ACCP Cardiology PRN @accpimtrprn
Shout out to Doug Jennings, Pharm.D. for co-authoring this HFSA consensus statement. Looks incredible. ACCP Cardiology PRN HFSA Expert Consensus Statement on the Medical Management of Patients on Durable Mechanical Circulatory Support onlinejcf.com/article/S1071-โฆ
Hot off the press at JCF: HFSA Expert Consensus Statement on the Medical Management of Patients on Durable Mechanical Circulatory Support Jennifer Cowger Doug Jennings, Pharm.D. Renzo Loyaga-Rendon Rebecca Cogswell Liviu Klein Palak Shah michaelkiernan Esther Vorovich MD onlinejcf.com/article/S1071-โฆ
Doug Jennings, Pharm.D. is a co-author on this up-coming paper based on the conference. #ISHLT2023
Michael Kirschner presenting our comparison between heart transplant to LVAD study, led by Dr. Takeda! kudos for amazing presentation! Gabriel Sayer Dor Lotan, MD Veli Topkara #ISHLT2023 Columbia University HeartSource Columbia Medicine Columbia Surgery Alexander Hajduczok, MD ๐บ๐ฆ๐ MRMehraMD Jennifer Haythe MD
Addition of hydrocortisone to norepinephrine was associated with a lower 28-day mortality in patients with septic shock, compared to the addition of vasopressin. buff.ly/3O0ab7i ACCP CRIT PRN
Congratulations to the Seminars in Thrombosis and Hemostasis 2022 Eberhard F. Mammen Young Investigator Award recipients! Rayna Anjis, Dr Aisling Rehill๐ฎ๐ช๐บ๐ฆ๐ต๐ธ, Harvey Roweth , Lauren (Poole) Hardy, Azita Talasaz and Stefano Lancellotti ๐๐๐ thieme-connect.com/products/ejourโฆ
The Difference Between Cystatin Cโ and Creatinine-Based eGFR in Heart Failure With Reduced Ejection Fraction bit.ly/3NeVRHr Alberto Pinsino Ali Husain Sumit Mohan Jai Radhakrishnan Doug Jennings, Pharm.D. Austin Nguonly Lorenzo Braghieri, MD ๐ฎ๐น๐บ๐ธ๐ช๐บ Gabriel Sayer Nir Uriel, MD MSc Melana Yuzefpolskaya Columbia Nephrology